FDA 483 - Lauren R. Klein, M.D. - April 23, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Lauren R. Klein, MD, MS, Sponsor-Investigator in Minneapolis, MN, was cited for significant deficiencies in conducting clinical investigations. The inspection revealed failures to submit Investigational New Drug (IND) applications, obtain informed consent, and ensure proper Institutional Review Board (IRB) oversight for study changes and adverse event reporting. Additionally, the firm failed to adhere to investigational plans, maintain adequate case histories, monitor studies, and keep proper investigational drug disposition records.
ID · bc1223ef-35d9-426d-9fc8-349fad1e261c